Windward Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.9M Sell
32,317
-608
-2% -$330K 1.29% 24
2025
Q4
$19.1M Sell
32,925
-1,141
-3% -$645K 1.51% 20
2025
Q3
$16.5M Sell
34,066
-344
-1% -$160K 1.32% 25
2025
Q2
$14M Sell
34,410
-211
-0.6% -$88.2K 1.18% 26
2025
Q1
$17.2M Sell
34,621
-539
-2% -$292K 1.49% 24
2024
Q4
$18.3M Sell
35,160
-452
-1% -$249K 1.4% 23
2024
Q3
$22M Sell
35,612
-208
-0.6% -$123K 1.68% 19
2024
Q2
$19.8M Sell
35,820
-949
-3% -$544K 1.67% 20
2024
Q1
$21.4M Sell
36,769
-506
-1% -$284K 1.78% 20
2023
Q4
$19.8M Sell
37,275
-89
-0.2% -$43.1K 1.72% 21
2023
Q3
$18.9M Sell
37,364
-779
-2% -$415K 1.85% 21
2023
Q2
$19.9M Buy
38,143
+208
+0.5% +$112K 1.8% 21
2023
Q1
$21.9M Buy
37,935
+893
+2% +$503K 2.02% 17
2022
Q4
$20.4M Sell
37,042
-187
-0.5% -$99.1K 2.21% 19
2022
Q3
$18.9M Buy
37,229
+64
+0.2% +$35.8K 2.14% 18
2022
Q2
$20.2M Buy
37,165
+239
+0.6% +$132K 2.17% 17
2022
Q1
$21.8M Sell
36,926
-84
-0.2% -$48.3K 1.95% 17
2021
Q4
$24.7M Buy
37,010
+57
+0.2% +$35.6K 2.05% 15
2021
Q3
$21.1M Sell
36,953
-99
-0.3% -$54.3K 1.96% 18
2021
Q2
$18.7M Sell
37,052
-77
-0.2% -$36.3K 1.74% 21
2021
Q1
$16.9M Buy
37,129
+19,769
+114% +$9.44M 1.69% 22
2020
Q4
$8.09M Buy
17,360
+16,258
+1,475% +$7.62M 0.81% 31
2020
Q3
$487K Sell
1,102
-14
-1% -$5.78K 0.05% 68
2020
Q2
$404K Sell
1,116
-11
-1% -$3.69K 0.05% 68
2020
Q1
$320K Sell
1,127
-92
-8% -$29K 0.04% 67
2019
Q4
$396K Sell
1,219
-8
-0.7% -$2.43K 0.04% 71
2019
Q3
$357K Sell
1,227
-42
-3% -$12K 0.04% 74
2019
Q2
$373K Sell
1,269
-31
-2% -$8.54K 0.05% 71
2019
Q1
$356K Sell
1,300
-10
-0.8% -$2.49K 0.05% 70
2018
Q4
$293K Sell
1,310
-26
-2% -$6.1K 0.04% 72
2018
Q3
$326K Buy
+1,336
New +$307K 0.04% 73

Other funds holding TMO

Windward Capital Management's TMO Position: Q1 2026 in Review

Windward Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q1 2026, selling an estimated $330K and leaving 32,317 shares worth $15.9M. The position accounts for 1.29% of the portfolio, ranked #24.

Windward Capital Management first reported a position in TMO in Q3 2018 and has held it in 31 quarters since. The position peaked at $24.7M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Windward Capital Management held 32,317 shares of Thermo Fisher Scientific worth $15.9M as of Q1 2026.
  • Windward Capital Management sold 608 Thermo Fisher Scientific shares in Q1 2026, an estimated $330K.
  • Thermo Fisher Scientific made up 1.29% of Windward Capital Management's portfolio in Q1 2026, its #24 holding.
  • Windward Capital Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 31 quarters since.
  • Windward Capital Management's Thermo Fisher Scientific position peaked at $24.7M in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Windward Capital Management's 13F filing for Q1 2026, filed 13 May 2026.